NYSE · Healthcare
ONTO INNOVATION INC. (ONTO)
As-reported financials and recent SEC filings for ONTO INNOVATION INC., latest fiscal period FY2024. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.01B
Net income
$136.8M
Net margin
13.6%
Diluted EPS
$2.78
ROE
6.5%
P/E (TTM)
151.4×
Market cap
$16.11B
Debt / equity
—
Income statement (as reported)
| Line | FY2024 | FY2024 | FY2022 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.01B | $987.3M | $815.9M | $1.01B | $788.9M |
| Gross profit | $499.8M | $515.3M | $420.3M | $539.2M | $429.1M |
| Operating income | $132.9M | $187.1M | $116.1M | $236.7M | $-156.4M |
| Net income | $136.8M | $201.7M | $121.2M | $223.3M | $142.3M |
| Diluted EPS | $2.78 | $4.06 | $2.46 | $4.49 | $2.86 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-05-27
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →8-K2026-05-21
View on EDGAR →Go deeper on ONTO
Search ONTO INNOVATION INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.